Aralez Bio is a biotechnology company that uses a proprietary enzyme engineering platform to manufacture noncanonical amino acids – key building blocks for next‑generation peptide and protein therapeutics – more efficiently, cleanly, and at scale for pharmaceutical and biotech partners.

By replacing traditional, resource‑intensive chemical synthesis with biocatalysis, Aralez Bio offers a cheaper, greener, and faster route to a broad portfolio of novel amino acid analogues, expanding medicinal chemistry “chemical space” while improving the sustainability and resilience of drug discovery and manufacturing supply chains.